Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapy-related preleukemic syndrome

R L Anderson, G C Bagby, K Richert-Boe

    Cancer
    |April 1, 1981
    PubMed
    Summary

    Cytotoxic drug exposure can lead to a preleukemic syndrome, progressing to acute nonlymphocytic leukemia (ANLL). These patients show increased chromosomal abnormalities and poor response to treatment, indicating early leukemia development.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    HER2 evaluation and its impact on breast cancer treatment decisions.

    Public health genomics·2011
    Same author

    Cigarette smoke induces genetic instability in airway epithelial cells by suppressing FANCD2 expression.

    British journal of cancer·2008
    Same author

    Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate.

    Leukemia·2003
    Same author

    The Fanconi anemia group C gene product: signaling functions in hematopoietic cells.

    Experimental hematology·2001
    Same author

    SNRPN methylation patterns in germ cell tumors as a reflection of primordial germ cell development.

    Genes, chromosomes & cancer·2001
    Same author

    Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor.

    Molecular pharmacology·2001

    Area of Science:

    • Hematology
    • Oncology
    • Toxicology

    Background:

    • Cytotoxic drugs are used to treat various primary diseases.
    • Preleukemic syndrome is a recognized precursor to acute leukemia.
    • The link between cytotoxic exposure and preleukemic syndrome warrants further investigation.

    Purpose of the Study:

    • To investigate the clinical course and cytogenetic characteristics of patients who developed preleukemic syndrome after cytotoxic drug exposure.
    • To determine if cytotoxic therapy influences the development and progression of preleukemic syndrome and acute nonlymphocytic leukemia (ANLL).

    Main Methods:

    • Retrospective analysis of eight patients with preleukemic syndrome following cytotoxic drug exposure.
    • Clinical data collection including survival times and response to therapy.
    • Cytogenetic analysis of bone marrow cells to identify chromosomal abnormalities.

    Main Results:

    • All eight patients developed acute nonlymphocytic leukemia (ANLL) after preleukemic syndrome.
    • Median survival was 11 months from preleukemic onset and 3 months after overt leukemia.
    • Five of six patients exhibited chromosomal abnormalities, a higher incidence than in unexposed preleukemic patients.
    • No patient responded to conventional antileukemic therapy.

    Conclusions:

    • Patients exposed to cytotoxic therapy who develop preleukemic syndrome may have an established leukemic clone.
    • The preleukemic phase in these patients can be considered early-stage leukemia.
    • Cytotoxic therapy is a significant risk factor for developing preleukemic syndrome and subsequent ANLL.

    Related Experiment Videos